Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Isr Med Assoc J
; 24(1): 9-10, 2022 Jan.
Article
en En
| MEDLINE
| ID: mdl-35077038
BACKGROUND: The Oxford-AstraZeneca vaccine ChAdOx1 (AZD1222, Vaxzevria) is playing a crucial role in counteracting the coronavirus disease-2019 (COVID-19) pandemic [1]. Since March 2021, reports of unexpected thrombotic events associated with thrombocytopenia and vaccination have been published [2]. To the best of our knowledge there is only one report about vaccination-associated myasthenia gravis (MG) occurring after a second dose of BNT162b2 (Pfizer-BioNTech).
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Bromuro de Piridostigmina
/
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
/
COVID-19
/
ChAdOx1 nCoV-19
/
Miastenia Gravis
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
Límite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
Isr Med Assoc J
Asunto de la revista:
MEDICINA
Año:
2022
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Israel